Genetic and phenotypic characterisation of <scp>HIV</scp> ‐associated aggressive B‐cell <scp>non‐Hodgkin</scp> lymphomas, which do not occur specifically in this population: diagnostic and prognostic implications-Reference-Cited by-同舟云学术

Genetic and phenotypic characterisation of HIV ‐associated aggressive B‐cell non‐Hodgkin lymphomas, which do not occur specifically in this population: diagnostic and prognostic implications

Published:2022-10-04 Issue:6 Volume:81 Page:826-840
ISSN:0309-0167
Container-title:Histopathology
language:en
Short-container-title:Histopathology

Author:

Baptista Maria Joao¹,Tapia Gustavo²,Muñoz‐Marmol Ana‐María²,Muncunill Josep¹,Garcia Olga¹,Montoto Silvia³,Gribben John G³,Calaminici Maria³,Martinez Antonio⁴,Veloza Luis⁴,Martínez‐Trillos Alejandra⁵,Aldamiz Teresa⁶,Menarguez Javier⁷,Terol María‐José⁸,Ferrandez Antonio⁹,Alcoceba Miguel¹⁰,Briones Javier¹¹,González‐Barca Eva¹²,Climent Fina¹³,Muntañola Ana¹⁴,Moraleda José‐María¹⁵,Provencio Mariano¹⁶,Abrisqueta Pau¹⁷,Abella Eugenia¹⁸,Colomo Lluis¹⁹,García‐Ballesteros Carlos²⁰,Garcia‐Caro Montserrat²¹,Sancho Juan‐Manuel¹,Ribera Josep‐Maria¹,Mate José‐Luis²,Navarro José‐Tomas¹^ORCID

Affiliation:

1. Department of Hematology, ICO‐Germans Trias i Pujol Hospital, Josep Carreras Leukaemia Research Institute (IJC) Universitat Autònoma de Barcelona Badalona Spain

2. Department of Pathology, Hospital Germans Trias i Pujol, IGTP Universitat Autònoma de Barcelona Badalona Spain

3. Centre for Haemato‐Oncology Barts Cancer Institute, Queen Mary University of London London UK

4. Department of Pathology, Hospital Clinic, IDIBAPS University of Barcelona Barcelona Spain

5. Department of Hematology, Hospital Clinic, IDIBAPS University of Barcelona Barcelona Spain

6. Department of Infectious Diseases Hospital Gregorio Marañón Madrid Spain

7. Department of Pathology Hospital Gregorio Marañón Madrid Spain

8. Department of Hematology and Oncology Hospital Clínic Universitari de València Valencia Spain

9. Department of Pathology Hospital Clínic Universitari de València Valencia Spain

10. Department of Hematology Hospital Universitario de Salamanca (HUS/IBSAL), CIBERONC and Centro de Investigación del Cáncer‐IBMCC (USAL‐CSIC) Salamanca Spain

11. Department of Hematology, Hospital de la Santa Creu i Sant Pau Josep Carreras Leukaemia Research Institute (IJC) Barcelona Spain

12. Department of Hematology ICO‐Hospital Duran i Reynals L'Hospitalet de Llobregat Spain

13. Department of Pathology Hospital Universitari de Bellvitge‐IDIBELL, L'Hospitalet de Llobregat Badalona Spain

14. Department of Clinical Hematology Hospital Universitari Mutua de Terrassa Terrassa Spain

15. Department of Hematology Hospital Clinico Universitario Virgen de la Arrixaca Murcia Spain

16. Department of Medical Oncology Hospital Universitario Puerta De Hierro Majadahonda Spain

17. Department of Hematology Hospital Vall d'Hebrón Barcelona Spain

18. Department of Hematology Hospital del Mar Barcelona Spain

19. Department of Pathology Hospital del Mar Barcelona Spain

20. Department of Hematology Hospital Arnau de Vilanova Valencia Spain

21. Department of Hematology Hospital de Mataro Barcelona Spain

Funder

“la Caixa” Foundation

Fundación Josep Carreras Contra la Leucemia

Instituto de Salud Carlos III

Publisher

Wiley

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/his.14798

Reference59 articles.

1. Changes in the influence of lymphoma- and HIV-specific factors on outcomes in AIDS-related non-Hodgkin lymphoma

2. HIV-infection impact on clinical–biological features and outcome of diffuse large B-cell lymphoma treated with R-CHOP in the combination antiretroviral therapy era

3. A lymphomagenic role for HIV beyond immune suppression?

4. Opposite Effects of HIV-1 p17 Variants on PTEN Activation and Cell Growth in B Cells

5. Human immunodeficiency virus (HIV) and Epstein-Barr virus (EBV) related lymphomas, pathology view point

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging entities: high-grade/large B-cell lymphoma with 11q aberration, large B-cell lymphoma with IRF4 rearrangement, and new molecular subgroups in large B-cell lymphomas. A report of the 2022 EA4HP/SH lymphoma workshop;Virchows Archiv;2023-08-09

2. Diffuse Large B-Cell Lymphoma in the HIV Setting;Cancers;2023-06-15

3. Burkitt’s Lymphoma in HIV-Infected Patients (Literature Review with Own Clinical Cases);Radiology - Practice;2023-05-01